Fig. 2.

The changes in oxidative stress markers before and after statin use. A: Rosuvastatin significantly reduced serum MDA levels in the acute stroke group but not in the chronic stroke group. B: There was a marked reduction in serum oxLDL level in both the acute and chronic stroke groups. C: There was no significant change in PCO in either stroke group after statin use. D: Surprisingly, 8-OHdG levels increased more in the acute stroke group than in the chronic stroke group after statin use. ^*p<0.05, ^**p<0.01. MDA: malondialdehyde, oxLDL: oxidized low-density lipoprotein, PCO: protein carbonyl content, Post-Tx: posttherapy, Pre-Tx: before therapy, 8-OHdG: 8-hydroxy-2'-deoxyguanosine.